Cigarette smoking is strongly associated with mutation of the K-ras gene in patients with primary adenocarcinoma of the lung
Top Cited Papers
Open Access
- 15 September 2001
- Vol. 92 (6) , 1525-1530
- https://doi.org/10.1002/1097-0142(20010915)92:6<1525::aid-cncr1478>3.0.co;2-h
Abstract
BACKGROUND The majority of lung carcinoma cases occur in current or former smokers. K‐ras gene mutations are common in lung adenocarcinoma and have been associated with cigarette smoking, asbestos exposure, and female gender. METHODS In the current study, the authors examined the contribution of cigarette smoking to K‐ras gene mutations in patients with primary lung adenocarcinoma. Smoking histories were obtained from 106 prospectively enrolled patients with primary adenocarcinoma of the lung. RESULTS K‐ras mutations were detected in the primary tumor using an allele‐specific ligation assay. Ninety‐two of the 106 patients (87%) with lung adenocarcinoma were smokers. Nonsmokers with this tumor were more likely to be women (11 of 14; 79%), whereas the majority of smokers (57%) were men. K‐ras mutations were detected in 40 of 106 tumors (38%) and were significantly more common in smokers compared with nonsmokers (43% vs. 0%; P = 0.001). CONCLUSIONS The results of the current study confirm and extend previous observations that smokers with adenocarcinoma of the lung are more likely to have K‐ras mutant tumors compared with nonsmokers. The strong link between cigarette smoking and K‐ras mutations in adenocarcinoma of the lung supports the role of specific tobacco carcinogens in the etiology of this malignancy. Cancer 2001;92:1525–30. © 2001 American Cancer Society.Keywords
This publication has 15 references indexed in Scilit:
- Implications and Prognostic Value of K-ras Mutation for Early-Stage Lung Cancer in WomenJNCI Journal of the National Cancer Institute, 1999
- Annual Report to the Nation on the Status of Cancer, 1973-1996, With a Special Section on Lung Cancer and Tobacco SmokingJNCI Journal of the National Cancer Institute, 1999
- Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung CancerJNCI Journal of the National Cancer Institute, 1999
- Prognostic Significance of K-ras Codon 12 Mutations in Patients With Resected Stage I and II Non–Small-Cell Lung CancerJournal of Clinical Oncology, 1999
- Genetic analysis of lung tumours of non-smoking subjects: p53 gene mutations are constantly associated with loss of heterozygosity in the FHIT locusBritish Journal of Cancer, 1998
- Prognostic value of loss of heterozygosity and KRAS2 mutations in lung adenocarcinomaInternational Journal of Cancer, 1998
- Revisions in the International System for Staging Lung CancerChest, 1997
- K‐ ras oncogene activation in lung adenocarcinomas from former smokers evidence that K‐ ras mutations are an early and irreversible event in the development of adenocarcinoma of the lungCancer, 1993
- Smoking and cancerThe American Journal of Medicine, 1992
- Smoking-Attributable Cancer Mortality in 1991: Is Lung Cancer Now the Leading Cause of Death Among Smokers in the United States?JNCI Journal of the National Cancer Institute, 1991